By April Rodgers Content Coordinator/FreeWire Magazine
If you’re a Gen Xer who’s recently been told it’s time for your shingles vaccine, here’s another reason not to put it off: It might just help your brain as much as it protects your skin. A new study published this week in Nature found that people who received the shingles vaccine were 20% less likely to develop dementia of any kind. That’s right—one simple shot could do more than prevent a painful rash. It might also protect your memories, your personality, and your independence.
A Shot, A Week, A Wild Coincidence
The study followed over 280,000 older adults in Wales and took advantage of an unusual twist of public health policy. Back in 2013, the country launched a shingles vaccination program that offered the shot to anyone who turned 79 by September 1—but not to those who had just turned 80. That one-week difference created a “natural experiment,” giving researchers a chance to compare two nearly identical groups—one that got the vaccine and one that didn’t. The results? Striking. The group that received the live virus shingles vaccine showed a significant drop in dementia cases. That level of protection, said Stanford researcher Dr. Pascal Geldsetzer, outperformed any other known intervention.
The Viral Link to Dementia
This isn’t the first time scientists have suspected that viral infections might play a bigger role in dementia than we previously thought. And shingles—a reactivation of the chickenpox virus—directly affects the nervous system, making it a prime suspect. Researchers believe the vaccine’s impact may be tied to reduced reactivations of the virus, an overall immune system boost, or some combination of the two. More research is needed to pin down the exact mechanism, but one thing is clear: a virus that gives you a rash might also give you a cognitive decline. And protecting against it might help preserve your mental sharpness.
A Win for Women?
Interestingly, the study also showed a stronger protective effect in women than in men. That might not surprise the ladies in the room—women tend to mount stronger immune responses and are more prone to shingles in the first place. Still, the finding could help scientists better understand how dementia develops differently across genders.
Shingrix: The Vaccine of Today
The original study examined the older, live-virus vaccine that was phased out in 2020. These days, most people receive Shingrix, the newer, FDA-approved shingles vaccine made by GlaxoSmithKline. Earlier research has linked Shingrix to lower dementia risk as well—especially in women—but the results weren’t as controlled. Still, the pattern is becoming harder to ignore.
What You Should Know
•Shingles is a painful rash caused by the reactivation of the chickenpox virus.
•Shingrix is recommended for adults 50 and older, and requires two doses.
•Dementia affects over 55 million people worldwide—and that number grows by 10 million each year.
While we still don’t have a cure for dementia, this study offers a new kind of hope: the idea that a routine preventive shot might do more than just protect your skin.
It might protect your memories. So if you’re 50 or older and your doctor says it’s time for Shingrix—don’t roll your eyes. Roll up your sleeve.
About The Author
